WaferGen Biosystems Partners With NuGen Technologies To Integrate Gene Expression Technology
Written on May 12, 2011
WaferGen Biosystems, Inc. is a leader in the development, manufacture, and sale of state-of-the-art systems for genome analysis for the life science and pharmaceutical industries. The company is developing high speed and low cost gene expression and genotyping technology. Based on collaborations...
Newly Launched NICE Quality Standards For CKD Form Framework For Health Care Professionals
Written on May 5, 2011
“Kidney disease is more common than people might think,” said Fiona Loud, Chair of the Kidney Alliance. The bean shaped organs responsible for a host of functions cause havoc when things go awry. Recently, The National Institute for Health and Clinical Excellence (NICE) has launched its new quality...
Adherex Enrolls First Patient in Clinical Trial For Metastatic Breast Cancer
Written on May 3, 2011
Adherex Technologies is a specialty biopharmaceutical company that focuses on the development of drug adjuncts that function to enhance the efficacy of currently used cancer drugs. The breakdown of drugs by the body is a principle factor that limits the therapeutic effect of medications, particularly so...
Insituvue To Present X-Ray Technology At OneMedForum NY 2011
Written on Apr 30, 2011
Insituvue, a new Pittsburgh medical device startup, is preparing to commercialize the Sonic Flashlight technology, a device developed at University of Pittsburgh that gives medical professionals a better view during procedures, such as inserting catheters and IVs. Insituvue plans to market two versions of...
NeoStem’s Suzhou Erye Receives 2 Pharma Industry Awards, Positioned For Future Growth
Written on Apr 28, 2011
NeoStem (AMEX:NBS) announced Tuesday that Chinese generic pharma company Suzhou Erye, in which it owns a 51% majority stake, has won two awards at the 2011 Chempharm Brand Summit, having been recognized for achievement in the industry.
During the Summit held in Chengdu City, China, Suzhou received the ...
Del Mar Pharmaceuticals Is Fighting Cancer One Molecule At A Time
Written on Apr 21, 2011
Cancer is a fighting word. But, Del Mar Pharmaceuticals, a recent addition to the roster of presenting companies at OneMedForum NY 2011, is ready for battle. The company’s mission is to build shareholder value by rapidly developing and commercializing proven anti-cancer therapies in orphan indications...
